• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用数字健康收集前列腺癌患者自我报告的电子结局:单臂试点试验。

Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.

作者信息

Tran Christine, Dicker Adam, Leiby Benjamin, Gressen Eric, Williams Noelle, Jim Heather

机构信息

Thomas Jefferson University, Sidney Kimmel Medical College and Cancer Center, Jefferson Center for Digital Health & Data Science, Philadelphia, PA, United States.

Levine Cancer Institute at Atrium Health, Southeast Radiation Oncology Group, Charlotte, NC, United States.

出版信息

J Med Internet Res. 2020 Mar 25;22(3):e12689. doi: 10.2196/12689.

DOI:10.2196/12689
PMID:32209536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7142743/
Abstract

BACKGROUND

Measuring patient-reported outcomes (PROs) requires an individual's perspective on their symptoms, functional status, and quality of life. Digital health enables remote electronic PRO (ePRO) assessments as a clinical decision support tool to facilitate meaningful provider interactions and personalized treatment.

OBJECTIVE

This study explored the feasibility and acceptability of collecting ePROs using validated health-related quality of life (HRQoL) questionnaires for prostate cancer.

METHODS

Using Apple ResearchKit software, the Strength Through Insight app was created with content from validated HRQoL tools 26-item Expanded Prostate Cancer Index Composite (EPIC) or EPIC for Clinical Practice and 8-item Functional Assessment of Cancer Therapy Advanced Prostate Symptom Index. In a single-arm pilot study with patients receiving prostate cancer treatment at Thomas Jefferson University Hospital and affiliates, participants were recruited, and instructed to download Strength Through Insight and complete ePROs once a week over 12 weeks. A mixed methods approach, including qualitative pre- and poststudy interviews, was used to evaluate the feasibility and acceptability of Strength Through Insight for the collection and care management of cancer treatment.

RESULTS

Thirty patients consented to the study; 1 patient failed to complete any of the questionnaires and was left out of the analysis of the intervention. Moreover, 86% (25/29) reached satisfactory questionnaire completion (defined as completion of 60% of weekly questions over 12 weeks). The lower bound of the exact one-sided 95% CI was 71%, exceeding the 70% feasibility threshold. Most participants self-identified with having a high digital literacy level (defined as the ability to use, understand, evaluate, and analyze information from multiple formats from a variety of digital sources), and only a few participants identified with having a low digital literacy level (defined as only having the ability to gather information on the Web). Interviews were thematically analyzed to reveal the following: (1) value of emotional support and wellness in cancer treatment, (2) rise of social patient advocacy in online patient communities and networks, (3) patient concerns over privacy, and (4) desire for personalized engagement tools.

CONCLUSIONS

Strength Through Insight was demonstrated as a feasible and acceptable method of data collection for ePROs. A high compliance rate confirmed the app as a reliable tool for patients with localized and advanced prostate cancer. Nearly all participants reported that using the smartphone app is easier than or equivalent to the traditional paper-and-pen approach, providing evidence of acceptability and support for the use of remote PRO monitoring. This study expands on current research involving the value of digital health, as a social and behavioral science, augmented with technology, can begin to contribute to population health management, as it shapes psychographic segmentation by demographic, socioeconomic, health condition, or behavioral factors to group patients by their distinct personalities and motivations, which influence their choices.

TRIAL REGISTRATION

ClinicalTrials.gov NC03197948; http://clinicaltrials.gov/ct2/show/NC03197948.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8016/7142743/502175e23708/jmir_v22i3e12689_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8016/7142743/502175e23708/jmir_v22i3e12689_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8016/7142743/502175e23708/jmir_v22i3e12689_fig1.jpg
摘要

背景

测量患者报告的结局(PROs)需要个人对其症状、功能状态和生活质量的看法。数字健康使远程电子PRO(ePRO)评估成为一种临床决策支持工具,以促进有意义的医患互动和个性化治疗。

目的

本研究探讨了使用经过验证的前列腺癌健康相关生活质量(HRQoL)问卷收集ePROs的可行性和可接受性。

方法

使用苹果ResearchKit软件,创建了“洞察力量”应用程序,其内容来自经过验证的HRQoL工具——26项扩展前列腺癌指数综合量表(EPIC)或临床实践用EPIC,以及8项癌症治疗功能评估前列腺症状高级指数。在一项单臂试点研究中,招募了在托马斯·杰斐逊大学医院及其附属医院接受前列腺癌治疗的患者,并指示他们下载“洞察力量”,并在12周内每周完成一次ePRO评估。采用混合方法,包括定性的研究前和研究后访谈,来评估“洞察力量”在癌症治疗数据收集和护理管理方面的可行性和可接受性。

结果

30名患者同意参与该研究;1名患者未完成任何问卷,被排除在干预分析之外。此外,86%(25/29)的患者达到了满意的问卷完成率(定义为在12周内完成每周问题的60%)。精确单侧95%置信区间的下限为71%,超过了70%的可行性阈值。大多数参与者自认为具有较高的数字素养水平(定义为能够使用、理解、评估和分析来自各种数字来源的多种格式信息的能力),只有少数参与者自认为数字素养水平较低(定义为仅具有在网络上收集信息的能力)。对访谈进行了主题分析,结果显示:(1)癌症治疗中情感支持和健康的价值;(2)在线患者社区和网络中社会患者倡导的兴起;(3)患者对隐私的担忧;(4)对个性化参与工具的渴望。

结论

“洞察力量”被证明是一种可行且可接受的ePRO数据收集方法。高依从率证实了该应用程序是局部和晚期前列腺癌患者的可靠工具。几乎所有参与者都报告说,使用智能手机应用程序比传统的纸笔方法更容易或相当,这为远程PRO监测的可接受性和支持提供了证据。本研究扩展了当前关于数字健康价值的研究,因为作为一门社会和行为科学,数字健康与技术相结合,可以开始为人群健康管理做出贡献,因为它根据人口统计学、社会经济、健康状况或行为因素对心理特征进行细分,以便根据患者独特的个性和动机对患者进行分组,而这些因素会影响他们的选择。

试验注册

ClinicalTrials.gov NC03197948;http://clinicaltrials.gov/ct2/show/NC03197948

相似文献

1
Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.利用数字健康收集前列腺癌患者自我报告的电子结局:单臂试点试验。
J Med Internet Res. 2020 Mar 25;22(3):e12689. doi: 10.2196/12689.
2
3
eHealth System for Collecting and Utilizing Patient Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care) Among Cancer Patients: Mixed Methods Approach to Evaluate Feasibility and Acceptability.癌症患者中用于个性化治疗和护理的患者报告结局测量收集与利用电子健康系统(PROMPT-Care):评估可行性和可接受性的混合方法
J Med Internet Res. 2017 Oct 2;19(10):e330. doi: 10.2196/jmir.8360.
4
Understanding the Feasibility, Acceptability, and Efficacy of a Clinical Pharmacist-led Mobile Approach (BPTrack) to Hypertension Management: Mixed Methods Pilot Study.理解临床药师主导的移动方法(BPTrack)在高血压管理中的可行性、可接受性和疗效:混合方法试点研究。
J Med Internet Res. 2020 Aug 11;22(8):e19882. doi: 10.2196/19882.
5
Digital Remote Monitoring Using an mHealth Solution for Survivors of Cancer: Protocol for a Pilot Observational Study.使用移动医疗解决方案对癌症幸存者进行数字远程监测:一项试点观察性研究方案。
JMIR Res Protoc. 2024 Apr 30;13:e52957. doi: 10.2196/52957.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Digital Medicine in Men with Advanced Prostate Cancer - A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment.数字医学在晚期前列腺癌男性患者中的应用——系统治疗患者电子患者报告结局的可行性研究。
Clin Oncol (R Coll Radiol). 2021 Dec;33(12):751-760. doi: 10.1016/j.clon.2021.04.008. Epub 2021 May 7.
8
Mobile App for Mental Health Monitoring and Clinical Outreach in Veterans: Mixed Methods Feasibility and Acceptability Study.用于退伍军人心理健康监测和临床外展的移动应用程序:混合方法的可行性和可接受性研究。
J Med Internet Res. 2020 Aug 11;22(8):e15506. doi: 10.2196/15506.
9
Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial.基于网络的远程行为干预在前列腺癌男性患者中的可行性和可接受性:四臂随机对照先导试验。
J Med Internet Res. 2020 Dec 31;22(12):e19238. doi: 10.2196/19238.
10
PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.PROutine:一项评估通过智能手机应用程序对晚期癌症患者的电子患者报告结局及依从性进行监测的可行性研究。
Ann Palliat Med. 2019 Apr;8(2):104-111. doi: 10.21037/apm.2017.07.05. Epub 2017 Oct 26.

引用本文的文献

1
Electronic patient-reported outcome systems and capabilities in cancer care: a systematic review.癌症护理中的电子患者报告结局系统及功能:一项系统综述
Front Digit Health. 2025 Aug 18;7:1560533. doi: 10.3389/fdgth.2025.1560533. eCollection 2025.
2
Knowledge map of self-reported outcomes in patients with prostate cancer: a bibliometric analysis (2014-2023).前列腺癌患者自我报告结局的知识图谱:一项文献计量分析(2014 - 2023年)
Front Urol. 2025 Aug 15;5:1574626. doi: 10.3389/fruro.2025.1574626. eCollection 2025.
3
The Role of mHealth Applications in Uro-Oncology: A Systematic Review and Future Directions.

本文引用的文献

1
WHEN HOURSING COMES FIRST, SO DO BENEFITS.当住房优先时,福利也会随之而来。
Hosp Health Netw. 2017 Jan;91(1):27.
2
Benefit of social media on patient engagement and satisfaction: Results of a 9-month, qualitative pilot study using Facebook.社交媒体对患者参与度和满意度的影响:一项为期 9 个月的使用 Facebook 的定性试点研究的结果。
Surgery. 2018 Mar;163(3):565-570. doi: 10.1016/j.surg.2017.09.056. Epub 2017 Nov 29.
3
Digital health is a cultural transformation of traditional healthcare.数字健康是传统医疗保健的一种文化变革。
移动健康应用在泌尿肿瘤学中的作用:系统评价与未来方向
Cancers (Basel). 2025 Aug 9;17(16):2613. doi: 10.3390/cancers17162613.
4
Evaluating an electronic patient-reported outcome monitoring system in patients with prostate cancer in routine clinical care: a prospective observational study.在常规临床护理中评估前列腺癌患者的电子患者报告结局监测系统:一项前瞻性观察性研究。
Qual Life Res. 2025 Apr 22. doi: 10.1007/s11136-025-03977-0.
5
Benefits and Limitations of Real-World Patient-Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers.患者、临床医生和指南制定者所认为的真实世界中患者报告的毒性症状监测对指南和护理的益处与局限性
Cancer Med. 2025 Apr;14(8):e70880. doi: 10.1002/cam4.70880.
6
Mobile apps for cancer patients: Identifying positive impacts and concerns.面向癌症患者的移动应用程序:识别积极影响与担忧之处。
Digit Health. 2025 Mar 3;11:20552076241305707. doi: 10.1177/20552076241305707. eCollection 2025 Jan-Dec.
7
Impact of immigration background on feasibility of electronic patient-reported outcomes in advanced urothelial cancer patients.移民背景对晚期尿路上皮癌患者电子患者报告结局可行性的影响。
Health Qual Life Outcomes. 2024 Dec 18;22(1):107. doi: 10.1186/s12955-024-02325-z.
8
Current Implementation of Digital Health in Chronic Disease Management: Scoping Review.慢性病管理中数字健康的当前实施情况:范围综述
J Med Internet Res. 2024 Dec 12;26:e53576. doi: 10.2196/53576.
9
A digital and nurse-led support intervention, first year after prostate cancer treatment: a single-arm feasibility study in a Swedish primary care setting.前列腺癌治疗后第一年的数字化及护士主导的支持性干预:瑞典初级保健环境中的单臂可行性研究
BMC Prim Care. 2024 Dec 3;25(1):409. doi: 10.1186/s12875-024-02669-x.
10
Advancing patient-centered cancer care: a systematic review of electronic patient-reported outcome measures.推进以患者为中心的癌症护理:电子患者报告结局指标的系统评价
Front Rehabil Sci. 2024 Sep 25;5:1427712. doi: 10.3389/fresc.2024.1427712. eCollection 2024.
Mhealth. 2017 Sep 14;3:38. doi: 10.21037/mhealth.2017.08.07. eCollection 2017.
4
A Qualitative Investigation on Patient Empowerment in Prostate Cancer.前列腺癌患者赋权的定性研究
Front Psychol. 2017 Jul 26;8:1215. doi: 10.3389/fpsyg.2017.01215. eCollection 2017.
5
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.一项评估常规癌症治疗期间症状监测的患者报告结局的试验的总生存结果。
JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156.
6
Digital technology and clinical decision making in depression treatment: Current findings and future opportunities.抑郁症治疗中的数字技术与临床决策:当前研究结果与未来机遇
Depress Anxiety. 2017 Jun;34(6):494-501. doi: 10.1002/da.22640. Epub 2017 Apr 28.
7
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients.随机试验比较肺癌患者的网络介导随访与常规监测。
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx029.
8
Development of the Digital Health Literacy Instrument: Measuring a Broad Spectrum of Health 1.0 and Health 2.0 Skills.数字健康素养工具的开发:衡量广泛的健康1.0和健康2.0技能
J Med Internet Res. 2017 Jan 24;19(1):e27. doi: 10.2196/jmir.6709.
9
Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies.了解影响患者和公众参与及招募到数字健康干预措施的因素:一项定性研究的系统评价
BMC Med Inform Decis Mak. 2016 Sep 15;16(1):120. doi: 10.1186/s12911-016-0359-3.
10
The P4 Health Spectrum - A Predictive, Preventive, Personalized and Participatory Continuum for Promoting Healthspan.P4健康光谱——促进健康寿命的预测性、预防性、个性化和参与性连续统一体。
Prog Cardiovasc Dis. 2017 Mar-Apr;59(5):506-521. doi: 10.1016/j.pcad.2016.08.002. Epub 2016 Aug 18.